Description
Dasatinib Tablets 50 mg is a medication used to treat certain types of cancer, particularly chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), especially in patients who have specific genetic mutations such as Philadelphia chromosome-positive (Ph+). Dasatinib is a tyrosine kinase inhibitor that works by blocking the activity of BCR-ABL, an abnormal protein that promotes the growth of cancer cells. By inhibiting this protein, Dasatinib helps to slow or stop the growth of leukemia cells.
The 50 mg dosage is typically taken once or twice daily, depending on the condition being treated and the patient’s response. Common side effects may include fatigue, headache, nausea, fluid retention, and low blood cell counts. Regular monitoring of blood counts and liver function is important to detect any potential side effects or complications.
Reviews
There are no reviews yet.